Magnesium lysinate bis Resolvin E1 (Thetis Pharmaceuticals)

N/A

Report date: 2025/07/04 16:55:29
NMEFirst In Class

Base Information

Drug NameMagnesium lysinate bis Resolvin E1 (Thetis Pharmaceuticals)
Drug Alias NameTP-317
ClassificationSmall molecules
Mechanisms of ActionLeukotriene B4 receptor agonists
TargetsLeukotriene B4 receptor
Therapy Area/IndicationsSolid tumoursCrohn DiseaseInflammatory Bowel Diseases +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesThetis Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumoursCrohn DiseaseInflammatory Bowel Diseases +[5
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A